|
The Cambridge Institute for Therapeutic Immunology and Infectious Diseases (CITIID) invites applications for sponsorship for an early career research award, such as a Wellcome Trust or Medical Research Council Career Development Award, or European Research Council Starting Grant. The award will be held in CITIID, either within the Jeffrey Cheah Biomedical Centre or within the University of Cambridge Department of Medicine Molecular Immunity Unit, housed within the MRC Laboratory of Molecular Biology. Shortlisted candidates will be invited to visit the institute to deliver a seminar and participate in a chalk talk to present their research plans. This process is designed to ensure a transparent, inclusive, and fair selection. We are seeking two early-career investigators with an outstanding track record in the fields of immunology or infectious diseases, compelling research plans that complement ongoing work at CITIID, and a strong commitment to contributing to a positive, collaborative research environment. We will provide advice and mentoring for the successful candidates to develop and submit a competitive award application from their current position. The successful candidates will be provided with research space for the duration of the CDA, a local mentor, access to PhD and MPhil students, and matched seed funding for equipment to strengthen the CDA proposal. Applications (CV and cover letter (Max 3 sides, including proposed research project) to be submitted to Dimple Patel, dp692@medschl.cam.ac.uk by July 29th 2025. Informal enquiries should be directed to Prof Menna Clatworthy, Director of CITIID (mrc38@medschl.cam.ac.uk). Successful candidates will be informed of shortlisting by August 11th 2025. Talk and chalk-talk visit day, September 12th 2025. About CITIID https://www.citiid.cam.ac.uk CITIID was established in 2019 and includes around 300 scientists within ~25 research groups, with laboratory space over three sites on the Cambridge Biomedical Campus. The Jeffrey Cheah Biomedical Centre, our main base within two floors of the centre also incorporates a state-of-the-art containment level 3 facility. Our investigators are also based within The Molecular Immunity Unit in the MRC Laboratory of Molecular Biology and Level 5 Addenbrookes Hospital. CITIID scientists study immune responses in health, autoimmunity, and infectious diseases and host-pathogen interactions (https://www.citiid.cam.ac.uk/research/recent-publications). Our experts work with NHS clinicians, industry, patients, as well as international research partners in Africa and Asia, leveraging state-of-the-art facilities to address important problems and find solutions that will improve patient outcomes and population health. The University actively supports equality, diversity and inclusion and encourages applications from all sections of society. The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
|
Apply
